Sara Pavitt

We are pleased to announce the launch of the Multidisciplinary Chiari Clinic at @dellchildrens. This new collaboration between pediatric neurosurgery and neurology offers coordinated, patient-centered care for children with Chiari malformations. @uthealthaustin @DellMedSchool

Join us in congratulating @dellchildrens headache chief Sara Pavitt, MD, who was selected as Clinician of the Year in the category of pediatric leadership by Ascension Medical Group!

Neurology Video Journal Club: Drs. Jessica Ailani & Ailna Masters-Israilov discuss a Neurology article on the effect of atogepant for preventive #migraine treatment. Watch now: bit.ly/3sfTdpV Read associated article: bit.ly/3kiQRpG @MedStarGUH @WeillCornell

In support of #MHAM, I’m sharing some interesting disease state information on migraine from Pfizer Medical. #PFEcolleague

Migraine is a painful, debilitating condition that impacts many aspects of daily life. Despite ~40 million people in the US living with migraine, it’s often dismissed as just a headache. We support #MHAM to raise awareness, address stigma & build a strong community of advocates

We're happy to share that our @PedNeuroscience program has ranked among the top #Neurology & #Neurosurgery programs by @USNews for 2022-2023. Congratulations to all our caregivers who made this possible! #USNewsandWorldReport #BestChildrensHospitals

ProudPALFPapa of these Amazing 30 grads, welcome to the AAN Leadership Family. Your Advisors & Faculty look forward to your certain future success & multiple achievements improving the lives of your patients, colleagues & profession #AANPALF #AANAdvocacy #AANLeadership

Very excited to catch up with old friends as we learn how to become amazing advocates! #AANPALF #AANadvocacy @PedNeuroscience @Stanford_Neuro @ChicagoMedEdu

PALF class 2022 off to a Great Start, mastering their sound bites today. Relaxing at Saw Mill market after a long day of media & advocacy training #AANPALF #AANadvocacy

Alterations in the structure & function of the brain in adolescents w new daily persistent #headache (#NDPH): A pilot MRI study @_edinaszabo Yu-Hsing Cindy Chang, Julie Shulman, @cbsieberg_PhD @NavilSethnaMD David Borsook, @ScottHo11820294 @alyssa_lebel …adachejournal.onlinelibrary.wiley.com/doi/10.1111/he…

Open Access: Comparison & predictors of #chronicmigraine vs. new daily persistent #headache (#NDPH) presenting w chronic #migraine phenotype KNagaraj, D Wei, @pul_fra H-Y Weng, S Waheed, N Vandenbussche, J Ong, @petergoadsby …adachejournal.onlinelibrary.wiley.com/doi/10.1111/he…

Incredibly excited to begin a transformative weekend with an inspiring group of neurologists!

Join us this Friday, 7/22 at 11 am CT for the International Pediatric #Headache Didactic Series with Marissa Lagman, MD, from @WCHospital, who will be discussing #migraine prevention treatment in kids and teens. Register here: bit.ly/3v7FdQt #childneurology #IPHDS

Congrats to Sara Pavitt, M.D., recently honored with the 2022 Child Neurology Resident Teaching Award! She was selected by the pediatric and @DellMedNeuro residents for her support of trainees to attain the knowledge & skills they need to become great clinicians.

Wonderful to see so many of my headache mentors this weekend! #AHSAM22 #mentorship

Watch: @NeurologyToday Editor-in-Chief @BrainHealthMD interviews @PavittSara about a novel pain management approach for treatment-refractory pediatric headaches. @AANMember #neurotwitter #pediatricneurology bit.ly/31weW2e

I feel so blessed to be working with such an amazing headache team! Migraine can cause significant disability to children and adolescents, but we are striving for these success stories with every one of our patients! @dellchildrens Check out uthealthaustin.org/blog/family-tr…

We were able to get this exciting work published for a great end of 2021! @NinaRiggins @aagelfand Efficacy and Safety of Repetitive Intravenous Sodium Valproate in Pedi... sciencedirect.com/science/articl…

It was incredible to evaluate the safety and efficacy of an inpatient treatment option for patients with refractory headache disorders! @aagelfand @ninariggins journals.lww.com/neurotodayonli…

Children with refractory #headache disorders get #pain relief from IV valproate in a 3- to 4-day hospital stay, according to a report from @CNSNeuroSoc #CNSAM. @AANMember #neurotwitter bit.ly/2YjQwYe